Dalcetrapib

Dalcetrapib
Dalcetrapib
Identifiers
CAS number 211513-37-0
PubChem 6918540
ChemSpider 5293737
Jmol-3D images Image 1
Properties
Molecular formula C23H35NO2S
Molar mass 389.5945
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Dalcetrapib or JTT-705 is a CETP inhibitor in development by Hoffmann–La Roche.[1] A 24 week clinical trial showed increased HDL levels.[2]

As of 2010 five phase II trials had started and there was no evidence of the raised blood pressure seen with torcetrapib.[2]

References